nonane has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T; Akaiwa, M; Amano, Y; Imaizumi, T; Kaneko, O; Koike, T; Kuramoto, K; Mori, K; Nagashima, T; Nigawara, T; Satake, Y; Shimazaki, M; Watanabe, K; Yamanaka, Y | 1 |
| MILLER, E | 2 |
3 other study(ies) available for nonane and Neoplasms
| Article | Year |
|---|---|
Discovery and biological evaluation of 1-{2,7-diazaspiro[3.5]nonan-2-yl}prop-2-en-1-one derivatives as covalent inhibitors of KRAS G12C with favorable metabolic stability and anti-tumor activity.
Topics: Alkanes; Animals; Cell Proliferation; Humans; Mice; Mutation; Neoplasms; Proto-Oncogene Proteins p21(ras); ras Proteins | 2022 |
Clinical trials of nonane in malignant disease.
Topics: Alkanes; Busulfan; Humans; Neoplasms | 1958 |
The effects of nonane on malignant disease.
Topics: Alkanes; Antineoplastic Agents; Neoplasms | 1961 |